Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Study Identifier
192024-018T
CT.gov Identifier
NCT00332540
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Ocular Hypertension
    • Study Drug
  • bimatoprost/timolol fixed combination
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes * Patient requires IOP-lowering drug in both eyes
    Exclusion Criteria:
    * Uncontrolled medical condition * Contraindication to beta-adrenoceptor antagonist therapy

    Protocol Summary

    The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

    Study Locations

    Location
    Status
    Location
    Rochester, New York, United States
    Status
    Not applicable
    Location
    Sherbrooke, Quebec, Canada
    Status
    Not applicable